Regulatory & Industry Liaison Committee
Charge: To develop and maintain relationships with industry members and with world regulatory agencies to address issues related to cartilage repair
Members: The committee shall consist of at least 6 members and not more than 8. At least one member will be an Industry representative ad at least one other member should be a Non-physician, Scientist member.
Responsibilities: Devise and disseminate an ICRS consensus opinion on regulatory matters confronting World Regulatory agencies regarding Cell therapies and scaffold Technology. Develop and maintain relationships with Regulatory bodies such as the FDA , EMEA, AMA and other world regulatory bodies. Host and develop joint meetings including regulators, industry representatives, scientists and physicians for the purpose of maintaining lines of communication and fostering better understanding between the various stakeholders. Develop and maintain relationships with Industry members and aide Scientific Program Committee and Executive Director in fostering sponsorship opportunities for the Society and its Scientific Program meeting
Election and Term of Appointment: The committee members and Chair will be elected and serve as delineated in the
Election Procedures.
Interim Chair, Ken Zaslav
Members: Leanna Caron, Bert Mandelbaum, Jack Farr, Michael Buschmann, Daniel Saris.
.